2 posts tagged “National Institutes of Health”

PatientsLikeMe creates largest open registry of IPF patients in the world

Posted August 22nd, 2013 by

Community One of Website’s Fastest Growing;
Reveals Real-World Picture Of Daily Life With the Rare Lung Disease


CAMBRIDGE, Mass.— August 22, 2013—
In a few short months, PatientsLikeMe has created the largest open registry of idiopathic pulmonary fibrosis (IPF) patients online, and some of the most current patient-reported data on the disease. The information the community has shared is providing new clues about the condition and giving a rare look into what it is like to live daily with a disease that has no known cause or cure.

According to the National Institutes of Health, pulmonary fibrosis causes scarring in deep lung tissue over time, making it harder for the lungs to move oxygen into the bloodstream. Cases where the cause of the disease is unknown are called IPF and usually affect middle-aged and older adults, more typically men, and an estimated 100,000 people in the United States.

The company’s focus on IPF accelerated earlier this year when it announced a collaboration with Boehringer Ingelheim to enhance its IPF patient community. Now more than 900 IPF patients use PatientsLikeMe to monitor their health and share information about their experiences with the condition. They can also connect with others like them and find IPF research studies in their area. In the process, members are contributing new, comprehensive data about the disease that will aid clinical research and the development of new treatments.

“We have become a magnet for people who want to learn about living with disease, and a central repository of real-world information on 2,000 common and rare conditions,” said Co-founder and President Ben Heywood. “It’s gratifying to see people gathering faster than ever before to support each other, live better, and contribute vital data to medical research.”

As the IPF community grows, PatientsLikeMe plans to study the challenges in diagnosing the disease and to ask patients about other top priorities for research. IPF patients interested in participating in research to improve understanding of IPF can sign up at http://www.patientslikeme.com/join/ipf/whatisipf.

The data shared on the website to date offer a snapshot of the IPF community’s members and highlight the effect the disease has on their lives:

  • The average age is 64; four out of five are older than 55.
  • 54% are male, 46% are female.
  • Approximately 15% report having familial IPF, a subtype of IPF thought to be genetically related.
  • An initial review of comorbidities shows that pulmonary hypertension, a condition that puts additional stress on the cardiovascular system, is most frequently cited. Other common co-morbidities include type-2 diabetes, gastro-esophageal reflux disease and osteoporosis.
  • Most report limitations to their activity and energy level. Over 90% experience shortness of breath during activities, while over 50% experience shortness of breath by just walking up a few stairs. About 7% are short of breath even when they are sitting down or at rest.
  • Close to 90% have noticed their energy level affected by IPF. About 35% say they often have to nap during the day or are always tired, no matter how much they sleep.
  • About 80% report having a cough. The majority report having a mild or moderate cough, but approximately 15% have severe coughing.
  • Approximately 11% have had unplanned hospitalizations as a result of their IPF in the past three months.

About PatientsLikeMe
PatientsLikeMe® (www.patientslikeme.com) is a patient network that improves lives and a real-time research platform that advances medicine. Through the network, patients connect with others who have the same disease or condition and track and share their own experiences. In the process, they generate data about the real-world nature of disease that help researchers, pharmaceutical companies, regulators, providers, and nonprofits develop more effective products, services and care. PatientsLikeMe is a trusted source for real-world disease information and a clinically robust resource that has published more than 35 peer-reviewed research studies. Visit us at www.patientslikeme.com or follow us via our blog, Twitter or Facebook.


PATIENTSLIKEME AND BOEHRINGER INGELHEIM ESTABLISH HEALTH INFORMATION COLLABORATION FOR PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

Posted February 28th, 2013 by

CAMBRIDGE, Mass. — February 28, 2013—On Rare Disease Day®, PatientsLikeMe announces a new collaboration with Boehringer Ingelheim to enhance its online patient community for people with idiopathic pulmonary fibrosis (IPF), a rare lung condition with no known cause, treatment or cure. Through a customized experience on PatientsLikeMe, IPF patients can now monitor their health and progress over time and connect with others to learn more about the condition.

“We are excited to partner with Boehringer Ingelheim, a leading pharmaceutical company, to support this patient initiative,” says PatientsLikeMe Co-founder and President Ben Heywood. “Rare diseases are sometimes called ‘orphan diseases’ because they affect so few people, and don’t attract significant research attention or funding. Our website is where patients count. They’re contributing their real-world experience to help others living with IPF and advance research.”

According to the National Institutes of Health, pulmonary fibrosis is a disease in which deep lung tissue becomes scarred over time, making it harder for the lungs to move oxygen into the bloodstream. Cases where the cause of the disease is unknown are called IPF and usually affect middle-aged and older adults, in all an estimated 100,000 people in the United States.

“I’d been short of breath for sometime but put it down to an unhealthy lifestyle. My doctor explained the X- ray had shown I had ‘stiff’ lungs and that I should see a specialist,” says 61-year old Ian Bannister, who was diagnosed with IPF in March 2010 and received a lung transplant a year later. He adds, “When you get a diagnosis like IPF, the first thing you do is look on the Internet for information. I wanted to hear directly from people who were either living with it or who had managed to get transplants. PatientsLikeMe is a great idea and gives you direct access to people who are, or have been, in the same situation as you.”
People who have any form of pulmonary fibrosis, including IPF, can join PatientsLikeMe for free at http://www.patientslikeme.com/join/ipf.

About PatientsLikeMe
PatientsLikeMe is a patient network that improves lives and a real-time research platform that advances medicine. Through the network, patients connect with others who have the same disease or condition and track and share their own experiences. In the process, they generate data about the real-world nature of disease that help researchers, pharmaceutical companies, regulators, providers and nonprofits develop more effective products, services and care. PatientsLikeMe is a trusted source for real-world disease information and a clinically robust resource that has published more than 30 peer-reviewed research studies . Visit us at www.patientslikeme.com or follow us via our blog , Twitter or Facebook .